Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2K Hold
728
0.02% 325
2025
Q4
$35.7K Hold
728
0.01% 330
2025
Q3
$31.4K Buy
+728
New +$28.4K 0.01% 327
2024
Q1
Sell
-140
Closed -$5.19K 504
2023
Q4
$5.19K Hold
140
﹤0.01% 406
2023
Q3
$5.08K Hold
140
﹤0.01% 410
2023
Q2
$4.99K Sell
140
-132
-49% -$4.74K ﹤0.01% 371
2023
Q1
$9.68K Hold
272
0.01% 350
2022
Q4
$9.56K Buy
+272
New +$9.06K 0.01% 332
2022
Q3
Sell
-272
Closed -$15K 468
2022
Q2
$15K Hold
272
0.01% 298
2022
Q1
$15K Hold
272
0.01% 305
2021
Q4
$15K Hold
272
0.01% 306
2021
Q3
$13K Hold
272
0.01% 319
2021
Q2
$14K Sell
272
-120
-31% -$5.77K 0.01% 315
2021
Q1
$17K Buy
392
+120
+44% +$5.45K 0.01% 291
2020
Q4
$13K Hold
272
0.01% 303
2020
Q3
$13K Sell
272
-58
-18% -$2.91K 0.01% 293
2020
Q2
$17K Sell
330
-294
-47% -$15.1K 0.02% 293
2020
Q1
$30K Buy
624
+180
+41% +$9.6K 0.03% 235
2019
Q4
$26K Hold
444
0.02% 263
2019
Q3
$24K Hold
444
0.02% 262
2019
Q2
$22K Buy
444
+114
+35% +$5.72K 0.02% 295
2019
Q1
$17K Buy
330
+132
+67% +$6.6K 0.01% 251
2018
Q4
$9K Hold
198
0.01% 262
2018
Q3
$10K Hold
198
0.01% 236
2018
Q2
$10K Hold
198
0.01% 234
2018
Q1
$10K Hold
198
0.01% 223
2017
Q4
$9K Buy
+198
New +$9.15K 0.01% 253

Other funds holding GSK

CNB Bank's GSK Position: Q1 2026 in Review

CNB Bank held its GSK (GSK) position steady in Q1 2026 at 728 shares worth $40.2K. The position accounts for 0.02% of the portfolio, ranked #325.

CNB Bank first reported a position in GSK in Q4 2017 and has held it in 27 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • CNB Bank held 728 shares of GSK worth $40.2K as of Q1 2026.
  • CNB Bank left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.02% of CNB Bank's portfolio in Q1 2026, its #325 holding.
  • CNB Bank first reported a position in GSK in Q4 2017 and has held it in 27 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.